| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |